First Trust Advisors
CLBT icon

First Trust Advisors’s Cellebrite CLBT Stock Holding History

First Trust Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Sell
108,324
-28,085
-21% -$371K ﹤0.01% 2090
2026
Q1 		$1.88M Buy
136,409
+44,912
+49% +$677K ﹤0.01% 1942
2025
Q4 		$1.65M Buy
91,497
+21,844
+31% +$392K ﹤0.01% 1967
2025
Q3 		$1.29M Buy
69,653
+48,360
+227% +$760K ﹤0.01% 2023
2025
Q2 		$341K Buy
+21,293
New +$380K ﹤0.01% 2380

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

First Trust Advisors's CLBT Position: Q2 2026 in Review

First Trust Advisors reduced its Cellebrite (CLBT) stake by 21% in Q2 2026, selling an estimated $371K and leaving 108,324 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2090.

First Trust Advisors first reported a position in CLBT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.88M in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • First Trust Advisors held 108,324 shares of Cellebrite worth $1.58M as of Q2 2026.
  • First Trust Advisors sold 28,085 Cellebrite shares in Q2 2026, an estimated $371K.
  • Cellebrite made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2090 holding.
  • First Trust Advisors first reported a position in Cellebrite in Q2 2025 and has held it in 5 quarters since.
  • First Trust Advisors's Cellebrite position peaked at $1.88M in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.